Archive - March 2018
Six new national standards are launched across UK
GSK no longer vying for Pfizer’s consumer assets
Tasigna cleared for use in children with rare leukemia
EU approves AZ’ potassium binder for hyperkalaemia
US, EU filings imminent for Novartis’ MS therapy siponimod
Whether Facts Matter in the Patent Eligibility Analysis: HP Files Petition for En Banc Rehearing
Sun Pharma gets green light for first U.S. biologic
GSK pulls bid for Pfizer OTC